-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Silexion Therapeutics Corp quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q2 2023 to Q3 2025.
- Silexion Therapeutics Corp Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $38K, a 99.3% decline year-over-year.
- Silexion Therapeutics Corp Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $96K.
- Silexion Therapeutics Corp annual Share-based Payment Arrangement, Expense for 2024 was $5.86M, a 4409% increase from 2023.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)